PHARMA EVIDENCE ApS: Financial statements 2012
CVR: 34586519
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 868,148 and a net result of DKK -447,585. Equity in the 2012 report amounted to DKK 409,973. The solvency ratio was 62.1%.
- Gross Profit
- DKK 868,148
- Profit/Loss
- DKK -447,585
- Equity
- DKK 409,973
- Total Assets
- DKK 660,129
Official annual report
Keep an eye on PHARMA EVIDENCE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 29, 2012, Tove Holm-Larsen is registered as director of PHARMA EVIDENCE ApS.
PHARMA EVIDENCE ApS was founded on May 29, 2012.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.